These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32517647)

  • 1. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
    Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
    J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
    Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
    J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling.
    Yang C; Li X; Gao W; Wang Q; Zhang L; Li Y; Li L; Zhang L
    Front Pharmacol; 2018; 9():682. PubMed ID: 29997510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
    Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
    Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation.
    Wang Y; Yang R; Gu J; Yin X; Jin N; Xie S; Wang Y; Chang H; Qian W; Shi J; Iqbal K; Gong CX; Cheng C; Liu F
    Neurobiol Aging; 2015 Jan; 36(1):188-200. PubMed ID: 25219467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
    Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
    Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.
    Adwan L; Subaiea GM; Basha R; Zawia NH
    J Neurochem; 2015 Apr; 133(2):266-72. PubMed ID: 25279694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
    Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
    Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
    Manoharan SD; Abdul Hamid H; Md Hashim NF; Cheema MS; Chiroma SM; Mustapha M; Mehat MZ
    Brain Res; 2024 Apr; 1829():148793. PubMed ID: 38309553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
    Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
    Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
    J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Single-Dose and Long-Term Ketamine Administration on Tau Phosphorylation-Related Enzymes GSK-3β, CDK5, PP2A, and PP2B in the Mouse Hippocampus.
    Li Y; Wen G; Ding R; Ren X; Jing C; Liu L; Yao J; Zhang G; Lu Y; Li B; Wu X
    J Mol Neurosci; 2020 Dec; 70(12):2068-2076. PubMed ID: 32705526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.
    Chu D; Tan J; Xie S; Jin N; Yin X; Gong CX; Iqbal K; Liu F
    J Alzheimers Dis; 2016; 49(2):365-75. PubMed ID: 26484916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of
    Zhang X; Wei YT; Wang JY; Liu HX; Zhu TT; Yan XK
    Zhongguo Zhen Jiu; 2023 Jul; 43(7):793-9. PubMed ID: 37429659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NLRP1-Dependent Pyroptosis Prevents Glycogen Synthase Kinase-3β Overactivation-Induced Hyperphosphorylated Tau in Rats.
    Liu X; Song W; Yu Y; Su J; Shi X; Yang X; Wang H; Liu P; Zou L
    Neurotox Res; 2022 Oct; 40(5):1163-1173. PubMed ID: 35951283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal truncation of GSK-3β enhances its dephosphorylation by PP2A.
    Jin N; Wu Y; Xu W; Gong CX; Iqbal K; Liu F
    FEBS Lett; 2017 Apr; 591(7):1053-1063. PubMed ID: 28267204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrobium nobile Lindl. alkaloid decreases Tau hyperphosphorylation via regulating PI3K/Akt/GSK-3β pathway in vitro and in vivo.
    Huang J; Huang N; Qiu Y; Shi J
    J Ethnopharmacol; 2024 Mar; 322():117592. PubMed ID: 38097026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.